Joseph A. Sparano
- Oncology top 0.05%
- Cancer Research top 0.1%
- Molecular Biology top 2%
- Pulmonary and Respiratory Medicine top 0.5%
- Pathology and Forensic Medicine top 0.2%
- Co-authors
- Nancy E. DavidsonGeorge W. SledgeAntonio C. WolffEdith A. PerezSilvana MartinoWilliam C. WoodRobert J. GraySoonmyung Paik
- Topics
- Breast Cancer Treatment Studies (102 papers)Cancer Treatment and Pharmacology (96 papers)HER2/EGFR in Cancer Research (83 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Joseph A. Sparano
377 papers receiving 15.5k citations
Hit Papers
Peers
Comparison fields: 5 of 151
- Oncology 10.4k
- Cancer Research 5.3k
- Molecular Biology 3.7k
- Pulmonary and Respiratory Medicine 2.7k
- Pathology and Forensic Medicine 2.3k
Countries citing papers authored by Joseph A. Sparano
This map shows the geographic impact of Joseph A. Sparano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph A. Sparano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph A. Sparano more than expected).
Fields of papers citing papers by Joseph A. Sparano
This network shows the impact of papers produced by Joseph A. Sparano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph A. Sparano. The network helps show where Joseph A. Sparano may publish in the future.
Co-authorship network of co-authors of Joseph A. Sparano
This figure shows the co-authorship network connecting the top 25 collaborators of Joseph A. Sparano. A scholar is included among the top collaborators of Joseph A. Sparano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph A. Sparano. Joseph A. Sparano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 8 | |
| 4 | 4 | |
| 5 | Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital Systembreakdown → | 521 |
| 6 | 9 | |
| 7 | Gene Expression Assays in Early-Stage Breast Cancer. | 1 |
| 8 | 6 | |
| 9 | 362 | |
| 10 | 66 | |
| 11 | 54 | |
| 12 | 131 | |
| 13 | Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199breakdown → | 953 |
| 14 | 47 | |
| 15 | 19 | |
| 16 | 15 | |
| 17 | 48 | |
| 18 | 21 | |
| 19 | 54 | |
| 20 | 28 |
About Joseph A. Sparano
Joseph A. Sparano is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 397 papers that have together received 15.9k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (102 papers), Cancer Treatment and Pharmacology (96 papers) and HER2/EGFR in Cancer Research (83 papers). The work is most often cited by research in Oncology (10.4k citations), Cancer Research (5.3k citations) and Pathology and Forensic Medicine (2.3k citations). Joseph A. Sparano has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Nancy E. Davidson, George W. Sledge, Antonio C. Wolff, Edith A. Perez, Silvana Martino, William C. Wood, Robert J. Gray, Soonmyung Paik, Lori J. Goldstein and Molin Wang. Their work appears in journals such as New England Journal of Medicine, The Lancet and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.